Summary

Psoriasis Treatment Market– Scope of Report

TMR’s report on the global Psoriasis Treatment Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Psoriasis Treatment Market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Psoriasis Treatment Market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the two-wheeler navigation display Market .

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global two-wheeler navigation display Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global two-wheeler navigation display Market. These serve as valuable tools for existing Market players as well as for entities interested in participating in the global two-wheeler navigation display Market .

The report delves into the competitive landscape of the global two-wheeler navigation display Market. Key players operating in the global Psoriasis Treatment Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Psoriasis Treatment Market profiled in this report.

Key Questions Answered in Global Psoriasis Treatment Market Report

• What is the sales/revenue generated by apheresis across all regions during the forecast period?
• What are the opportunities in the global two-wheeler navigation display Market ?
• What are the major drivers, restraints, opportunities, and threats in the Market ?
• Which regional Market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the Market positions of different companies operating in the global Market ?

Psoriasis Treatment Market– Research Objectives and Research Approach

The comprehensive report on the global Psoriasis Treatment Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Psoriasis Treatment Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global two-wheeler navigation display Market.

ページTOPに戻る

Table of Contents

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Psoriasis Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Segment Definition

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Psoriasis Treatment Market Analysis and Forecasts, 2020 to 2035

4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

5.1. Regulatory Landscape across Key Regions / Countries

5.2. Psoriasis Treatment Market Trends

5.3. PORTER’s Five Forces Analysis

5.4. PESTEL Analysis

5.5. Key Purchase Metrics for End-users

5.6. Brand and Pricing Analysis

5.7. Treatment Algorithm

5.8. Distributors Landscape

6. Global Psoriasis Treatment Market Analysis and Forecasts, By Drug Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast By Drug Type, 2020 to 2035

6.3.1. Biologics

6.3.1.1. TNF Inhibitors

6.3.1.2. Interleukin Inhibitors

6.3.1.2.1. IL-17 Inhibitors

6.3.1.2.2. IL-23 Inhibitors

6.3.1.2.3. Others

6.3.2. Small Molecule Drugs

6.3.2.1. Tyrosine kinase 2 (TYK2) inhibitors

6.3.2.2. Phosphodiesterase 4 (PDE4) inhibitor

6.3.2.3. Corticosteroids

6.3.2.4. Retinoids

6.3.2.5. Calcineurin inhibitors

6.3.2.6. Others

6.4. Market Attractiveness By Drug Type

7. Global Psoriasis Treatment Market Analysis and Forecasts, By Type

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast By Type, 2020 to 2035

7.3.1. Branded

7.3.2. Generic

7.4. Market Attractiveness By Type

8. Global Psoriasis Treatment Market Analysis and Forecasts, By Types of Psoriasis

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast By Types of Psoriasis, 2020 to 2035

8.3.1. Plaque Psoriasis

8.3.2. Inverse Psoriasis

8.3.3. Guttate Psoriasis

8.3.4. Pustular Psoriasis

8.3.5. Others

8.4. Market Attractiveness By Types of Psoriasis

9. Global Psoriasis Treatment Market Analysis and Forecasts, By Route of Administration

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Market Value Forecast By Route of Administration, 2020 to 2035

9.3.1. Oral

9.3.2. Topical

9.3.3. Parenteral

9.4. Market Attractiveness By Route of Administration

10. Global Psoriasis Treatment Market Analysis and Forecasts, By Distribution Channel

10.1. Introduction & Definition

10.2. Key Findings / Developments

10.3. Market Value Forecast By Distribution Channel, 2020 to 2035

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Online Pharmacies

10.4. Market Attractiveness By Distribution Channel

11. Global Psoriasis Treatment Market Analysis and Forecasts, By Region

11.1. Key Findings

11.2. Market Value Forecast By Region

11.2.1. North America

11.2.2. Europe

11.2.3. Asia Pacific

11.2.4. Latin America

11.2.5. Middle East & Africa

11.3. Market Attractiveness By Region

12. North America Psoriasis Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast By Drug Type, 2020 to 2035

12.2.1. Biologics

12.2.1.1. TNF Inhibitors

12.2.1.2. Interleukin Inhibitors

12.2.1.2.1. IL-17 Inhibitors

12.2.1.2.2. IL-23 Inhibitors

12.2.1.2.3. Others

12.2.2. Small Molecule Drugs

12.2.2.1. Tyrosine kinase 2 (TYK2) inhibitors

12.2.2.2. Phosphodiesterase 4 (PDE4) inhibitor

12.2.2.3. Corticosteroids

12.2.2.4. Retinoids

12.2.2.5. Calcineurin inhibitors

12.2.2.6. Others

12.3. Market Value Forecast By Type, 2020 to 2035

12.3.1. Branded

12.3.2. Generic

12.4. Market Value Forecast By Types of Psoriasis, 2020 to 2035

12.4.1. Plaque Psoriasis

12.4.2. Inverse Psoriasis

12.4.3. Guttate Psoriasis

12.4.4. Pustular Psoriasis

12.4.5. Others

12.5. Market Value Forecast By Route of Administration, 2020 to 2035

12.5.1. Oral

12.5.2. Topical

12.5.3. Topical

12.6. Market Value Forecast By Distribution Channel, 2020 to 2035

12.6.1. Hospital Pharmacies

12.6.2. Retail Pharmacies

12.6.3. Online Pharmacies

12.7. Market Value Forecast By Country, 2020 to 2035

12.7.1. U.S.

12.7.2. Canada

12.8. Market Attractiveness Analysis

12.8.1. By Drug Type

12.8.2. By Type

12.8.3. By Types of Psoriasis

12.8.4. By Route of Administration

12.8.5. By Distribution Channel

12.8.6. By Country

13. Europe Psoriasis Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast By Drug Type, 2020 to 2035

13.2.1. Biologics

13.2.1.1. TNF Inhibitors

13.2.1.2. Interleukin Inhibitors

13.2.1.2.1. IL-17 Inhibitors

13.2.1.2.2. IL-23 Inhibitors

13.2.1.2.3. Others

13.2.2. Small Molecule Drugs

13.2.2.1. Tyrosine kinase 2 (TYK2) inhibitors

13.2.2.2. Phosphodiesterase 4 (PDE4) inhibitor

13.2.2.3. Corticosteroids

13.2.2.4. Retinoids

13.2.2.5. Calcineurin inhibitors

13.2.2.6. Others

13.3. Market Value Forecast By Type, 2020 to 2035

13.3.1. Branded

13.3.2. Generic

13.4. Market Value Forecast By Types of Psoriasis, 2020 to 2035

13.4.1. Plaque Psoriasis

13.4.2. Inverse Psoriasis

13.4.3. Guttate Psoriasis

13.4.4. Pustular Psoriasis

13.4.5. Others

13.5. Market Value Forecast By Route of Administration, 2020 to 2035

13.5.1. Oral

13.5.2. Topical

13.5.3. Topical

13.6. Market Value Forecast By Distribution Channel, 2020 to 2035

13.6.1. Hospital Pharmacies

13.6.2. Retail Pharmacies

13.6.3. Online Pharmacies

13.7. Market Value Forecast By Country/Sub-region, 2020 to 2035

13.7.1. Germany

13.7.2. U.K.

13.7.3. France

13.7.4. Italy

13.7.5. Spain

13.7.6. Switzerland

13.7.7. The Netherlands

13.7.8. Rest of Europe

13.8. Market Attractiveness Analysis

13.8.1. By Drug Type

13.8.2. By Type

13.8.3. By Types of Psoriasis

13.8.4. By Route of Administration

13.8.5. By Distribution Channel

13.8.6. By Country/Sub-region

14. Asia Pacific Psoriasis Treatment Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Market Value Forecast By Drug Type, 2020 to 2035

14.2.1. Biologics

14.2.1.1. TNF Inhibitors

14.2.1.2. Interleukin Inhibitors

14.2.1.2.1. IL-17 Inhibitors

14.2.1.2.2. IL-23 Inhibitors

14.2.1.2.3. Others

14.2.2. Small Molecule Drugs

14.2.2.1. Tyrosine kinase 2 (TYK2) inhibitors

14.2.2.2. Phosphodiesterase 4 (PDE4) inhibitor

14.2.2.3. Corticosteroids

14.2.2.4. Retinoids

14.2.2.5. Calcineurin inhibitors

14.2.2.6. Others

14.3. Market Value Forecast By Type, 2020 to 2035

14.3.1. Branded

14.3.2. Generic

14.4. Market Value Forecast By Types of Psoriasis, 2020 to 2035

14.4.1. Plaque Psoriasis

14.4.2. Inverse Psoriasis

14.4.3. Guttate Psoriasis

14.4.4. Pustular Psoriasis

14.4.5. Others

14.5. Market Value Forecast By Route of Administration, 2020 to 2035

14.5.1. Oral

14.5.2. Topical

14.5.3. Topical

14.6. Market Value Forecast By Distribution Channel, 2020 to 2035

14.6.1. Hospital Pharmacies

14.6.2. Retail Pharmacies

14.6.3. Online Pharmacies

14.7. Market Value Forecast By Country/Sub-region, 2020 to 2035

14.7.1. China

14.7.2. Japan

14.7.3. India

14.7.4. Australia & New Zealand

14.7.5. South Korea

14.7.6. Rest of Asia Pacific

14.8. Market Attractiveness Analysis

14.8.1. By Drug Type

14.8.2. By Type

14.8.3. By Types of Psoriasis

14.8.4. By Route of Administration

14.8.5. By Distribution Channel

14.8.6. By Country/Sub-region

15. Latin America Psoriasis Treatment Market Analysis and Forecast

15.1. Introduction

15.1.1. Key Findings

15.2. Market Value Forecast By Drug Type, 2020 to 2035

15.2.1. Biologics

15.2.1.1. TNF Inhibitors

15.2.1.2. Interleukin Inhibitors

15.2.1.2.1. IL-17 Inhibitors

15.2.1.2.2. IL-23 Inhibitors

15.2.1.2.3. Others

15.2.2. Small Molecule Drugs

15.2.2.1. Tyrosine kinase 2 (TYK2) inhibitors

15.2.2.2. Phosphodiesterase 4 (PDE4) inhibitor

15.2.2.3. Corticosteroids

15.2.2.4. Retinoids

15.2.2.5. Calcineurin inhibitors

15.2.2.6. Others

15.3. Market Value Forecast By Type, 2020 to 2035

15.3.1. Branded

15.3.2. Generic

15.4. Market Value Forecast By Types of Psoriasis, 2020 to 2035

15.4.1. Plaque Psoriasis

15.4.2. Inverse Psoriasis

15.4.3. Guttate Psoriasis

15.4.4. Pustular Psoriasis

15.4.5. Others

15.5. Market Value Forecast By Route of Administration, 2020 to 2035

15.5.1. Oral

15.5.2. Topical

15.5.3. Topical

15.6. Market Value Forecast By Distribution Channel, 2020 to 2035

15.6.1. Hospital Pharmacies

15.6.2. Retail Pharmacies

15.6.3. Online Pharmacies

15.7. Market Value Forecast By Country/Sub-region, 2020 to 2035

15.7.1. Brazil

15.7.2. Mexico

15.7.3. Argentina

15.7.4. Rest of Latin America

15.8. Market Attractiveness Analysis

15.8.1. By Drug Type

15.8.2. By Type

15.8.3. By Types of Psoriasis

15.8.4. By Route of Administration

15.8.5. By Distribution Channel

15.8.6. By Country/Sub-region

16. Middle East & Africa Psoriasis Treatment Market Analysis and Forecast

16.1. Introduction

16.1.1. Key Findings

16.2. Market Value Forecast By Drug Type, 2020 to 2035

16.2.1. Biologics

16.2.1.1. TNF Inhibitors

16.2.1.2. Interleukin Inhibitors

16.2.1.2.1. IL-17 Inhibitors

16.2.1.2.2. IL-23 Inhibitors

16.2.1.2.3. Others

16.2.2. Small Molecule Drugs

16.2.2.1. Tyrosine kinase 2 (TYK2) inhibitors

16.2.2.2. Phosphodiesterase 4 (PDE4) inhibitor

16.2.2.3. Corticosteroids

16.2.2.4. Retinoids

16.2.2.5. Calcineurin inhibitors

16.2.2.6. Others

16.3. Market Value Forecast By Type, 2020 to 2035

16.3.1. Branded

16.3.2. Generic

16.4. Market Value Forecast By Types of Psoriasis, 2020 to 2035

16.4.1. Plaque Psoriasis

16.4.2. Inverse Psoriasis

16.4.3. Guttate Psoriasis

16.4.4. Pustular Psoriasis

16.4.5. Others

16.5. Market Value Forecast By Route of Administration, 2020 to 2035

16.5.1. Oral

16.5.2. Topical

16.5.3. Topical

16.6. Market Value Forecast By Distribution Channel, 2020 to 2035

16.6.1. Hospital Pharmacies

16.6.2. Retail Pharmacies

16.6.3. Online Pharmacies

16.7. Market Value Forecast By Country/Sub-region, 2020 to 2035

16.7.1. GCC Countries

16.7.2. South Africa

16.7.3. Rest of Middle East & Africa

16.8. Market Attractiveness Analysis

16.8.1. By Drug Type

16.8.2. By Type

16.8.3. By Types of Psoriasis

16.8.4. By Route of Administration

16.8.5. By Distribution Channel

16.8.6. By Country/Sub-region

17. Competition Landscape

17.1. Market Player – Competition Matrix (By Tier and Size of companies)

17.2. Market Share Analysis By Company (2024)

17.3. Company Profiles

17.3.1. Bristol-Myers Squibb Company

17.3.1.1. Company Overview

17.3.1.2. Financial Overview

17.3.1.3. Product Portfolio

17.3.1.4. Business Strategies

17.3.1.5. Recent Developments

17.3.2. AbbVie Inc

17.3.2.1. Company Overview

17.3.2.2. Financial Overview

17.3.2.3. Product Portfolio

17.3.2.4. Business Strategies

17.3.2.5. Recent Developments

17.3.3. Amgen Inc

17.3.3.1. Company Overview

17.3.3.2. Financial Overview

17.3.3.3. Product Portfolio

17.3.3.4. Business Strategies

17.3.3.5. Recent Developments

17.3.4. AstraZeneca

17.3.4.1. Company Overview

17.3.4.2. Financial Overview

17.3.4.3. Product Portfolio

17.3.4.4. Business Strategies

17.3.4.5. Recent Developments

17.3.5. Eli Lilly and Company

17.3.5.1. Company Overview

17.3.5.2. Financial Overview

17.3.5.3. Product Portfolio

17.3.5.4. Business Strategies

17.3.5.5. Recent Developments

17.3.6. Johnson & Johnson Services, Inc.

17.3.6.1. Company Overview

17.3.6.2. Financial Overview

17.3.6.3. Product Portfolio

17.3.6.4. Business Strategies

17.3.6.5. Recent Developments

17.3.7. LEO Pharma A/S

17.3.7.1. Company Overview

17.3.7.2. Financial Overview

17.3.7.3. Product Portfolio

17.3.7.4. Business Strategies

17.3.7.5. Recent Developments

17.3.8. Merck & Co., Inc.,

17.3.8.1. Company Overview

17.3.8.2. Financial Overview

17.3.8.3. Product Portfolio

17.3.8.4. Business Strategies

17.3.8.5. Recent Developments

17.3.9. Novartis AG

17.3.9.1. Company Overview

17.3.9.2. Financial Overview

17.3.9.3. Product Portfolio

17.3.9.4. Business Strategies

17.3.9.5. Recent Developments

17.3.10. Boehringer Ingelheim Pharmaceuticals, Inc.

17.3.10.1. Company Overview

17.3.10.2. Financial Overview

17.3.10.3. Product Portfolio

17.3.10.4. Business Strategies

17.3.10.5. Recent Developments

17.3.11. Arcutis Biotherapeutics, Inc

17.3.11.1. Company Overview

17.3.11.2. Financial Overview

17.3.11.3. Product Portfolio

17.3.11.4. Business Strategies

17.3.11.5. Recent Developments

17.3.12. Dermavant Sciences, Inc.

17.3.12.1. Company Overview

17.3.12.2. Financial Overview

17.3.12.3. Product Portfolio

17.3.12.4. Business Strategies

17.3.12.5. Recent Developments

17.3.13. TIEFENBACHER GROUP

17.3.13.1. Company Overview

17.3.13.2. Financial Overview

17.3.13.3. Product Portfolio

17.3.13.4. Business Strategies

17.3.13.5. Recent Developments

17.3.14. UCB S.A.

17.3.14.1. Company Overview

17.3.14.2. Financial Overview

17.3.14.3. Product Portfolio

17.3.14.4. Business Strategies

17.3.14.5. Recent Developments

17.3.15. Bausch Health

17.3.15.1. Company Overview

17.3.15.2. Financial Overview

17.3.15.3. Product Portfolio

17.3.15.4. Business Strategies

17.3.15.5. Recent Developments

17.3.16. Sun Pharmaceutical Industries Limited

17.3.16.1. Company Overview

17.3.16.2. Financial Overview

17.3.16.3. Product Portfolio

17.3.16.4. Business Strategies

17.3.16.5. Recent Developments

17.3.17. Akeso Biopharma Co., Ltd.

17.3.17.1. Company Overview

17.3.17.2. Financial Overview

17.3.17.3. Product Portfolio

17.3.17.4. Business Strategies

17.3.17.5. Recent Developments

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 01: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035

Table 02: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Biologics, 2020 to 2035

Table 03: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Small Molecule Drugs, 2020 to 2035

Table 04: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Type, 2020 to 2035

Table 05: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Types of Psoriasis, 2020 to 2035

Table 06: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035

Table 07: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035

Table 08: Global Psoriasis Treatment Market Value (US$ Bn) Forecast, By Region, 2020 to 2035

Table 09: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035

Table 10: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035

Table 11: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Biologics, 2020 to 2035

Table 12: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Small Molecule Drugs, 2020 to 2035

Table 13: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Type, 2020 to 2035

Table 14: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Types of Psoriasis, 2020 to 2035

Table 15: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035

Table 16: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035

Table 17: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035

Table 18: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035

Table 19: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Biologics, 2020 to 2035

Table 20: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Small Molecule Drugs, 2020 to 2035

Table 21: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Type, 2020 to 2035

Table 22: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Types of Psoriasis, 2020 to 2035

Table 23: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035

Table 24: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035

Table 25: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035

Table 26: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035

Table 27: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Biologics, 2020 to 2035

Table 28: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Small Molecule Drugs, 2020 to 2035

Table 29: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Type, 2020 to 2035

Table 30: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Types of Psoriasis, 2020 to 2035

Table 31: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035

Table 32: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035

Table 33: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035

Table 34: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035

Table 35: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Biologics, 2020 to 2035

Table 36: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Small Molecule Drugs, 2020 to 2035

Table 37: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Type, 2020 to 2035

Table 38: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Types of Psoriasis, 2020 to 2035

Table 39: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035

Table 40: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035

Table 41: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035

Table 42: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035

Table 43: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Biologics, 2020 to 2035

Table 44: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Small Molecule Drugs, 2020 to 2035

Table 45: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Type, 2020 to 2035

Table 46: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Types of Psoriasis, 2020 to 2035

Table 47: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035

Table 48: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035List of Figures

Figure 01: Global Psoriasis Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035

Figure 02: Global Psoriasis Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035

Figure 03: Global Psoriasis Treatment Market Revenue (US$ Bn), by Biologics, 2020 to 2035

Figure 04: Global Psoriasis Treatment Market Revenue (US$ Bn), by Small Molecule Drugs, 2020 to 2035

Figure 05: Global Psoriasis Treatment Market Value Share Analysis, By Type, 2024 and 2035

Figure 06: Global Psoriasis Treatment Market Attractiveness Analysis, By Type, 2025 to 2035

Figure 07: Global Psoriasis Treatment Market Revenue (US$ Bn), by Branded, 2020 to 2035

Figure 08: Global Psoriasis Treatment Market Revenue (US$ Bn), by Generics, 2020 to 2035

Figure 09: Global Psoriasis Treatment Market Value Share Analysis, By Types of Psoriasis, 2024 and 2035

Figure 10: Global Psoriasis Treatment Market Attractiveness Analysis, By Types of Psoriasis, 2025 to 2035

Figure 11: Global Psoriasis Treatment Market Revenue (US$ Bn), by Plaque Psoriasis, 2020 to 2035

Figure 12: Global Psoriasis Treatment Market Revenue (US$ Bn), by Inverse Psoriasis, 2020 to 2035

Figure 13: Global Psoriasis Treatment Market Revenue (US$ Bn), by Guttate Psoriasis, 2020 to 2035

Figure 14: Global Psoriasis Treatment Market Revenue (US$ Bn), by Pustular Psoriasis, 2020 to 2035

Figure 15: Global Psoriasis Treatment Market Revenue (US$ Bn), by Others, 2020 to 2035

Figure 16: Global Psoriasis Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 17: Global Psoriasis Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035

Figure 18: Global Psoriasis Treatment Market Revenue (US$ Bn), by Oral, 2020 to 2035

Figure 19: Global Psoriasis Treatment Market Revenue (US$ Bn), by Topical, 2020 to 2035

Figure 20: Global Psoriasis Treatment Market Revenue (US$ Bn), by Parenteral, 2020 to 2035

Figure 21: Global Psoriasis Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 22: Global Psoriasis Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035

Figure 23: Global Psoriasis Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020 to 2035

Figure 24: Global Psoriasis Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020 to 2035

Figure 25: Global Psoriasis Treatment Market Revenue (US$ Bn), by Online Pharmacies, 2020 to 2035

Figure 26: Global Psoriasis Treatment Market Value Share Analysis, By Region, 2024 and 2035

Figure 27: Global Psoriasis Treatment Market Attractiveness Analysis, By Region, 2025 to 2035

Figure 28: North America Psoriasis Treatment Market Value (US$ Bn) Forecast, 2020 to 2035

Figure 29: North America Psoriasis Treatment Market Value Share Analysis, by Country, 2024 and 2035

Figure 30: North America Psoriasis Treatment Market Attractiveness Analysis, by Country, 2025 to 2035

Figure 31: North America Psoriasis Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035

Figure 32: North America Psoriasis Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035

Figure 33: North America Psoriasis Treatment Market Value Share Analysis, By Type, 2024 and 2035

Figure 34: North America Psoriasis Treatment Market Attractiveness Analysis, By Type, 2025 to 2035

Figure 35: North America Psoriasis Treatment Market Value Share Analysis, By Types of Psoriasis, 2024 and 2035

Figure 36: North America Psoriasis Treatment Market Attractiveness Analysis, By Types of Psoriasis, 2025 to 2035

Figure 37: North America Psoriasis Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 38: North America Psoriasis Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035

Figure 39: North America Psoriasis Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 40: North America Psoriasis Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035

Figure 41: Europe Psoriasis Treatment Market Value (US$ Bn) Forecast, 2020 to 2035

Figure 42: Europe Psoriasis Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035

Figure 43: Europe Psoriasis Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035

Figure 44: Europe Psoriasis Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035

Figure 45: Europe Psoriasis Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035

Figure 46: Europe Psoriasis Treatment Market Value Share Analysis, By Type, 2024 and 2035

Figure 47: Europe Psoriasis Treatment Market Attractiveness Analysis, By Type, 2025 to 2035

Figure 48: Europe Psoriasis Treatment Market Value Share Analysis, By Types of Psoriasis, 2024 and 2035

Figure 49: Europe Psoriasis Treatment Market Attractiveness Analysis, By Types of Psoriasis, 2025 to 2035

Figure 50: Europe Psoriasis Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 51: Europe Psoriasis Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035

Figure 52: Europe Psoriasis Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 53: Europe Psoriasis Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035

Figure 54: Asia Pacific Psoriasis Treatment Market Value (US$ Bn) Forecast, 2020 to 2035

Figure 55: Asia Pacific Psoriasis Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035

Figure 56: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035

Figure 57: Asia Pacific Psoriasis Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035

Figure 58: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035

Figure 59: Asia Pacific Psoriasis Treatment Market Value Share Analysis, By Type, 2024 and 2035

Figure 60: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, By Type, 2025 to 2035

Figure 61: Asia Pacific Psoriasis Treatment Market Value Share Analysis, By Types of Psoriasis, 2024 and 2035

Figure 62: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, By Types of Psoriasis, 2025 to 2035

Figure 63: Asia Pacific Psoriasis Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 64: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035

Figure 65: Asia Pacific Psoriasis Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 66: Asia Pacific Psoriasis Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035

Figure 67: Latin America Psoriasis Treatment Market Value (US$ Bn) Forecast, 2020 to 2035

Figure 68: Latin America Psoriasis Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035

Figure 69: Latin America Psoriasis Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035

Figure 70: Latin America Psoriasis Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035

Figure 71: Latin America Psoriasis Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035

Figure 72: Latin America Psoriasis Treatment Market Value Share Analysis, By Type, 2024 and 2035

Figure 73: Latin America Psoriasis Treatment Market Attractiveness Analysis, By Type, 2025 to 2035

Figure 74: Latin America Psoriasis Treatment Market Value Share Analysis, By Types of Psoriasis, 2024 and 2035

Figure 75: Latin America Psoriasis Treatment Market Attractiveness Analysis, By Types of Psoriasis, 2025 to 2035

Figure 76: Latin America Psoriasis Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 77: Latin America Psoriasis Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035

Figure 78: Latin America Psoriasis Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 79: Latin America Psoriasis Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035

Figure 80: Middle East & Africa Psoriasis Treatment Market Value (US$ Bn) Forecast, 2020 to 2035

Figure 81: Middle East & Africa Psoriasis Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035

Figure 82: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035

Figure 83: Middle East & Africa Psoriasis Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035

Figure 84: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035

Figure 85: Middle East & Africa Psoriasis Treatment Market Value Share Analysis, By Type, 2024 and 2035

Figure 86: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, By Type, 2025 to 2035

Figure 87: Middle East & Africa Psoriasis Treatment Market Value Share Analysis, By Types of Psoriasis, 2024 and 2035

Figure 88: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, By Types of Psoriasis, 2025 to 2035

Figure 89: Middle East & Africa Psoriasis Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035

Figure 90: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035

Figure 91: Middle East & Africa Psoriasis Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035

Figure 92: Middle East & Africa Psoriasis Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035